All News
GlobalData highlights implications of US tariffs on IVD market
According to GlobalData, these tariffs are expected to impact all 510(k)-approved medical devices manufactured outside of the US
Read MoreWhat ‘Fertilization President’ Trump Can Learn From State Efforts To Expand IVF Access
State-level efforts to regulate fertility coverage reveal the gauntlet of budgetary and political hurdles such initiatives face — obstacles that have led to millions of people being left out even wh
Read MoreMoms in Crisis, Jobs Lost: The Human Cost of Trump’s Addiction Funding Cuts
In many cases, the money flowed to addiction recovery programs that help rebuild lives by driving people to medical appointments and court hearings, crafting résumés and training them for new jobs,
Read MoreSTAT+: Struggling lobbyists, panicked clients: D.C. comes to grips with Trump’s second term
Trump's second term is playing out a lot differently than health care companies and their lobbyists hoped for.
Read MoreSTAT+: With the FDA in turmoil, the ‘revolving door’ with industry is spinning faster
HHS Robert F. Kennedy Jr. has railed against a “revolving door” between drug companies and the FDA. But HHS' actions now seem to be causing that door to spin faster.
Read MoreOpinion: NIH cuts will set back research into the rare disease that has terrorized my family
Jim Higgins has an inherited cancer syndrome that has killed his father, sister, and two daughters. He fears NIH cuts will hurt important research progress made in recent years.
Read MoreSTAT+: Trump’s first 100 days, seen through 5 lives: Grants terminated. Dreams crushed. Futures in the balance
STAT spoke with people living through the historic disruptions threatening the future of biomedical research in the U.S.
Read MoreIFFCO Kisan Finance’s Arogya Vistaar initiative to deliver primary healthcare services across Bihar
This project aims to deliver primary healthcare services by creating an Integrated Rural Dig-Physical Healthcare Services network in association with DocOnline
Read MoreBRIC-inStem conducts first gene therapy trial for Haemophilia
Union Minister for Science and Technology Dr Jitendra Singh inspected the various facilities at BRIC-inStem and underscored the strategic importance of biotechnology
Read MoreSTAT+: Women’s Health Initiative to receive NIH funding after all
A spokesperson said Thursday that "NIH initially exceeded its internal targets for contract reductions" in explaining the reversal days after cuts had been announced.
Read More